GFAFX
Price
$83.75
Change
-$3.33 (-3.82%)
Updated
Jun 5 closing price
Net Assets
360.63B
PLGJX
Price
$8.71
Change
-$0.29 (-3.22%)
Updated
Jun 5 closing price
Net Assets
6.11B
Interact to see
Advertisement

GFAFX vs PLGJX

Header iconGFAFX vs PLGJX Comparison
Open Charts GFAFX vs PLGJXBanner chart's image
GFAFX vs PLGJX Comparison Chart in %
View a ticker or compare two or three
VS
GFAFX vs. PLGJX commentary
Jun 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a Hold and PLGJX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 361B vs. PLGJX (6.11B). GFAFX pays higher dividends than PLGJX: GFAFX (0.20) vs PLGJX (0.00). GFAFX was incepted earlier than PLGJX: GFAFX (25 years) vs PLGJX (25 years). PLGJX (0.80) is less costly to investors than GFAFX (0.65). PLGJX is a more actively managed with annual turnover of: 34.70 vs. GFAFX (32.00). GFAFX has a lower initial minimum investment than PLGJX: GFAFX (250) vs PLGJX (1000). GFAFX annual gain was more profitable for investors over the last year : 8.94 vs. PLGJX (-13.85). GFAFX return over 5 years is better than : 17.71 vs. PLGJX (-48.52).
GFAFXPLGJXGFAFX / PLGJX
Total Expense Ratio0.650.7883%
Annual Report Gross Expense Ratio0.650.8081%
Fund Existence25 years25 years-
Gain YTD5.1871.397371%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets361B6.11B5,905%
Annual Yield % from dividends0.200.00-
Returns for 1 year8.94-13.85-65%
Returns for 3 years45.82-23.93-191%
Returns for 5 years17.71-48.52-37%
Returns for 10 years101.18-13.88-729%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCYO10.480.16
+1.55%
Pure Cycle Corp
MATX187.320.03
+0.02%
Matsons
BNS80.56-0.83
-1.02%
Bank of Nova Scotia
VTOL41.64-0.45
-1.07%
Bristow Group
BRNS0.65-0.05
-6.95%
Barinthus Biotherapeutics plc